Abstract
Background and objectivesType 2 diabetes and associated CKD disproportionately affect blacks. It is uncertain if racial disparities in type 2 diabetes-associated CKD are driven by biologic factors that influence propensity to CKD or by differences in type 2 diabetes care.Design, setting, participants, & measurementsWe conducted a post hoc analysis of 1937 black and 6372 white participants of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial to examine associations of black race with change in eGFR and risks of developing microalbuminuria, macroalbuminuria, incident CKD (eGFR<60 ml/min per 1.73m2, ≥25% decrease from baseline eGFR, and eGFR slope <−1.6 ml/min per 1.73 m2 per year), and kidney failure or serum creatinine >3.3 mg/dl.ResultsDuring a median follow-up that ranged between 4.4 and 4.7 years, 278 black participants (58 per 1000 person-years) and 981 white participants (55 per 1000 person-years) developed microalbuminuria, 122 black participants (16 per 1000 person-years) and 374 white participants (14 per 1000 person-years) developed macroalbuminuria, 111 black participants (21 per 1000 person-years) and 499 white participants (28 per 1000 person-years) developed incident CKD, and 59 black participants (seven per 1000 person-years) and 178 white participants (six per 1000 person-years) developed kidney failure or serum creatinine >3.3 mg/dl. Compared with white participants, black participants had lower risks of incident CKD (hazard ratio, 0.73; 95% confidence intervals, 0.57 to 0.92). There were no significant differences by race in eGFR decline or in risks of microalbuminuria, macroalbuminuria, and kidney failure or of serum creatinine >3.3 mg/dl.ConclusionsBlack participants enrolled in a randomized controlled trial had lower rates of incident CKD compared with white participants. Rates of eGFR decline, microalbuminuria, macroalbuminuria, and kidney failure did not vary by race.
Publisher
American Society of Nephrology (ASN)
Subject
Transplantation,Nephrology,Critical Care and Intensive Care Medicine,Epidemiology
Reference34 articles.
1. US Department of Health and Human Services Centers for Disease Control and Prevention: National diabetes fact sheet: National estimates and general information on diabetes and prediabetes in the United States, 2014. Available at: https://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf. Accessed July 19, 2017
2. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
3. Centers for Disease Control and Prevention: Chronic disease prevention and health promotion, 2016. Available at: https://www.cdc.gov/chronicdisease/resources/publications/aag/diabetes.htm. Accessed July 19, 2017
4. A Community-Based Study of Explanatory Factors for the Excess Risk for Early Renal Function Decline in Blacks vs Whites With Diabetes
5. The Excess Incidence of Diabetic End-Stage Renal Disease Among Blacks
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Diabetes and migration;Die Diabetologie;2024-01
2. Diabetes und Migration;Diabetologie und Stoffwechsel;2023-10
3. Diabetes and Migration;Experimental and Clinical Endocrinology & Diabetes;2023-06
4. Confronting racial and ethnic disparities in diabetic kidney disease;Nature;2023-03-08
5. Diabetes and migration;Die Diabetologie;2023-02-02